Placebo + Oxytocin for obesity

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trials ended early. Its trials were stopped early. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 13 Apr 2018: Trial registered, NCT03497988
  2. 26 Dec 2018: Trial withdrawn, NCT03497988

The trials

NCT03497988: Intranasal Oxytocin and Food Intake in Obese Adolescents

State
Withdrawn before it started
Phase
Phase 2
People
0 taking part
Started
Sep 2018
Primary completion
Jun 2020
Arms
Syntocinon (=Oxytocin), then Placebo, Placebo, then Syntocinon (=Oxytocin)
Results
None posted
  1. 13 Apr 2018: Trial registered
  2. 26 Dec 2018: Trial withdrawn

How the status changed

  1. 19 Nov 2026: First set: Trials ended early

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.